HEADER HYDROLASE 10-JAN-01 1HWW TITLE GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SWAINSONINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-MANNOSIDASE II; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GOLGI ALPHA-MANNOSIDASE II; COMPND 5 EC: 3.2.1.114; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DROSOPHILA MELANOGASTER; SOURCE 3 ORGANISM_COMMON: FRUIT FLY; SOURCE 4 ORGANISM_TAXID: 7227; SOURCE 5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 8 EXPRESSION_SYSTEM_CELL: S2 KEYWDS N-TERMINAL ALPHA-BETA DOMAIN, THREE HELIX BUNDLE, 2 C-TERMINAL BETA KEYWDS 2 BARRELS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.H.VAN DEN ELSEN,D.A.KUNTZ,D.R.ROSE REVDAT 8 06-NOV-24 1HWW 1 REMARK REVDAT 7 09-AUG-23 1HWW 1 HETSYN REVDAT 6 29-JUL-20 1HWW 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE REVDAT 5 04-APR-18 1HWW 1 REMARK REVDAT 4 13-JUL-11 1HWW 1 VERSN REVDAT 3 24-FEB-09 1HWW 1 VERSN REVDAT 2 01-APR-03 1HWW 1 JRNL REVDAT 1 10-JAN-02 1HWW 0 JRNL AUTH J.M.VAN DEN ELSEN,D.A.KUNTZ,D.R.ROSE JRNL TITL STRUCTURE OF GOLGI ALPHA-MANNOSIDASE II: A TARGET FOR JRNL TITL 2 INHIBITION OF GROWTH AND METASTASIS OF CANCER CELLS. JRNL REF EMBO J. V. 20 3008 2001 JRNL REFN ISSN 0261-4189 JRNL PMID 11406577 JRNL DOI 10.1093/EMBOJ/20.12.3008 REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 84829 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4286 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.87 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9401 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2550 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 506 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 985 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.55000 REMARK 3 B22 (A**2) : 0.12000 REMARK 3 B33 (A**2) : 0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.11 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.19 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.787 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 42.28 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HWW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-01. REMARK 100 THE DEPOSITION ID IS D_1000012640. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54189 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : OSMIC FOCUSSING OPTICS (MIRRORS) REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 87633 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 69.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.45200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1HTY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, MPD, TRIS, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.45100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.23600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.00750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.23600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.45100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.00750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER WITH ONE COPY OF THE REMARK 300 PROTEIN IN THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1045 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 95 -83.86 -173.39 REMARK 500 ASP A 106 -62.41 -129.67 REMARK 500 THR A 162 -64.74 72.72 REMARK 500 GLN A 227 -51.36 -134.81 REMARK 500 PHE A 287 4.30 -67.18 REMARK 500 SER A 411 -121.74 39.06 REMARK 500 HIS A 471 7.70 -69.60 REMARK 500 PHE A 519 -4.73 -58.77 REMARK 500 GLU A 537 119.39 -166.85 REMARK 500 ILE A 549 -48.59 -139.49 REMARK 500 LEU A 550 117.84 -165.70 REMARK 500 PRO A 562 36.66 -77.89 REMARK 500 ARG A 653 160.46 174.01 REMARK 500 SER A 703 162.71 -49.75 REMARK 500 ASN A 732 54.74 -91.77 REMARK 500 SER A 762 -8.01 78.63 REMARK 500 SER A 833 -13.27 -153.37 REMARK 500 ASP A 839 -159.49 -127.18 REMARK 500 SER A 855 -175.15 -171.74 REMARK 500 GLU A 991 86.89 43.92 REMARK 500 GLU A 992 -166.80 -121.60 REMARK 500 HIS A 993 91.79 33.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1102 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 90 NE2 REMARK 620 2 ASP A 92 OD1 93.5 REMARK 620 3 ASP A 204 OD1 98.3 165.2 REMARK 620 4 HIS A 471 NE2 99.4 88.4 98.4 REMARK 620 5 SWA A1103 O13 90.8 81.4 89.5 166.0 REMARK 620 6 SWA A1103 O11 160.2 87.3 78.6 100.4 69.7 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HTY RELATED DB: PDB REMARK 900 1HTY CONTAINS THE SAME PROTEIN COMPLEXED WITH TRIS DBREF 1HWW A 31 1045 UNP Q24451 MAN2_DROME 94 1108 SEQRES 1 A 1015 CYS GLN ASP VAL VAL GLN ASP VAL PRO ASN VAL ASP VAL SEQRES 2 A 1015 GLN MET LEU GLU LEU TYR ASP ARG MET SER PHE LYS ASP SEQRES 3 A 1015 ILE ASP GLY GLY VAL TRP LYS GLN GLY TRP ASN ILE LYS SEQRES 4 A 1015 TYR ASP PRO LEU LYS TYR ASN ALA HIS HIS LYS LEU LYS SEQRES 5 A 1015 VAL PHE VAL VAL PRO HIS SER HIS ASN ASP PRO GLY TRP SEQRES 6 A 1015 ILE GLN THR PHE GLU GLU TYR TYR GLN HIS ASP THR LYS SEQRES 7 A 1015 HIS ILE LEU SER ASN ALA LEU ARG HIS LEU HIS ASP ASN SEQRES 8 A 1015 PRO GLU MET LYS PHE ILE TRP ALA GLU ILE SER TYR PHE SEQRES 9 A 1015 ALA ARG PHE TYR HIS ASP LEU GLY GLU ASN LYS LYS LEU SEQRES 10 A 1015 GLN MET LYS SER ILE VAL LYS ASN GLY GLN LEU GLU PHE SEQRES 11 A 1015 VAL THR GLY GLY TRP VAL MET PRO ASP GLU ALA ASN SER SEQRES 12 A 1015 HIS TRP ARG ASN VAL LEU LEU GLN LEU THR GLU GLY GLN SEQRES 13 A 1015 THR TRP LEU LYS GLN PHE MET ASN VAL THR PRO THR ALA SEQRES 14 A 1015 SER TRP ALA ILE ASP PRO PHE GLY HIS SER PRO THR MET SEQRES 15 A 1015 PRO TYR ILE LEU GLN LYS SER GLY PHE LYS ASN MET LEU SEQRES 16 A 1015 ILE GLN ARG THR HIS TYR SER VAL LYS LYS GLU LEU ALA SEQRES 17 A 1015 GLN GLN ARG GLN LEU GLU PHE LEU TRP ARG GLN ILE TRP SEQRES 18 A 1015 ASP ASN LYS GLY ASP THR ALA LEU PHE THR HIS MET MET SEQRES 19 A 1015 PRO PHE TYR SER TYR ASP ILE PRO HIS THR CYS GLY PRO SEQRES 20 A 1015 ASP PRO LYS VAL CYS CYS GLN PHE ASP PHE LYS ARG MET SEQRES 21 A 1015 GLY SER PHE GLY LEU SER CYS PRO TRP LYS VAL PRO PRO SEQRES 22 A 1015 ARG THR ILE SER ASP GLN ASN VAL ALA ALA ARG SER ASP SEQRES 23 A 1015 LEU LEU VAL ASP GLN TRP LYS LYS LYS ALA GLU LEU TYR SEQRES 24 A 1015 ARG THR ASN VAL LEU LEU ILE PRO LEU GLY ASP ASP PHE SEQRES 25 A 1015 ARG PHE LYS GLN ASN THR GLU TRP ASP VAL GLN ARG VAL SEQRES 26 A 1015 ASN TYR GLU ARG LEU PHE GLU HIS ILE ASN SER GLN ALA SEQRES 27 A 1015 HIS PHE ASN VAL GLN ALA GLN PHE GLY THR LEU GLN GLU SEQRES 28 A 1015 TYR PHE ASP ALA VAL HIS GLN ALA GLU ARG ALA GLY GLN SEQRES 29 A 1015 ALA GLU PHE PRO THR LEU SER GLY ASP PHE PHE THR TYR SEQRES 30 A 1015 ALA ASP ARG SER ASP ASN TYR TRP SER GLY TYR TYR THR SEQRES 31 A 1015 SER ARG PRO TYR HIS LYS ARG MET ASP ARG VAL LEU MET SEQRES 32 A 1015 HIS TYR VAL ARG ALA ALA GLU MET LEU SER ALA TRP HIS SEQRES 33 A 1015 SER TRP ASP GLY MET ALA ARG ILE GLU GLU ARG LEU GLU SEQRES 34 A 1015 GLN ALA ARG ARG GLU LEU SER LEU PHE GLN HIS HIS ASP SEQRES 35 A 1015 GLY ILE THR GLY THR ALA LYS THR HIS VAL VAL VAL ASP SEQRES 36 A 1015 TYR GLU GLN ARG MET GLN GLU ALA LEU LYS ALA CYS GLN SEQRES 37 A 1015 MET VAL MET GLN GLN SER VAL TYR ARG LEU LEU THR LYS SEQRES 38 A 1015 PRO SER ILE TYR SER PRO ASP PHE SER PHE SER TYR PHE SEQRES 39 A 1015 THR LEU ASP ASP SER ARG TRP PRO GLY SER GLY VAL GLU SEQRES 40 A 1015 ASP SER ARG THR THR ILE ILE LEU GLY GLU ASP ILE LEU SEQRES 41 A 1015 PRO SER LYS HIS VAL VAL MET HIS ASN THR LEU PRO HIS SEQRES 42 A 1015 TRP ARG GLU GLN LEU VAL ASP PHE TYR VAL SER SER PRO SEQRES 43 A 1015 PHE VAL SER VAL THR ASP LEU ALA ASN ASN PRO VAL GLU SEQRES 44 A 1015 ALA GLN VAL SER PRO VAL TRP SER TRP HIS HIS ASP THR SEQRES 45 A 1015 LEU THR LYS THR ILE HIS PRO GLN GLY SER THR THR LYS SEQRES 46 A 1015 TYR ARG ILE ILE PHE LYS ALA ARG VAL PRO PRO MET GLY SEQRES 47 A 1015 LEU ALA THR TYR VAL LEU THR ILE SER ASP SER LYS PRO SEQRES 48 A 1015 GLU HIS THR SER TYR ALA SER ASN LEU LEU LEU ARG LYS SEQRES 49 A 1015 ASN PRO THR SER LEU PRO LEU GLY GLN TYR PRO GLU ASP SEQRES 50 A 1015 VAL LYS PHE GLY ASP PRO ARG GLU ILE SER LEU ARG VAL SEQRES 51 A 1015 GLY ASN GLY PRO THR LEU ALA PHE SER GLU GLN GLY LEU SEQRES 52 A 1015 LEU LYS SER ILE GLN LEU THR GLN ASP SER PRO HIS VAL SEQRES 53 A 1015 PRO VAL HIS PHE LYS PHE LEU LYS TYR GLY VAL ARG SER SEQRES 54 A 1015 HIS GLY ASP ARG SER GLY ALA TYR LEU PHE LEU PRO ASN SEQRES 55 A 1015 GLY PRO ALA SER PRO VAL GLU LEU GLY GLN PRO VAL VAL SEQRES 56 A 1015 LEU VAL THR LYS GLY LYS LEU GLU SER SER VAL SER VAL SEQRES 57 A 1015 GLY LEU PRO SER VAL VAL HIS GLN THR ILE MET ARG GLY SEQRES 58 A 1015 GLY ALA PRO GLU ILE ARG ASN LEU VAL ASP ILE GLY SER SEQRES 59 A 1015 LEU ASP ASN THR GLU ILE VAL MET ARG LEU GLU THR HIS SEQRES 60 A 1015 ILE ASP SER GLY ASP ILE PHE TYR THR ASP LEU ASN GLY SEQRES 61 A 1015 LEU GLN PHE ILE LYS ARG ARG ARG LEU ASP LYS LEU PRO SEQRES 62 A 1015 LEU GLN ALA ASN TYR TYR PRO ILE PRO SER GLY MET PHE SEQRES 63 A 1015 ILE GLU ASP ALA ASN THR ARG LEU THR LEU LEU THR GLY SEQRES 64 A 1015 GLN PRO LEU GLY GLY SER SER LEU ALA SER GLY GLU LEU SEQRES 65 A 1015 GLU ILE MET GLN ASP ARG ARG LEU ALA SER ASP ASP GLU SEQRES 66 A 1015 ARG GLY LEU GLY GLN GLY VAL LEU ASP ASN LYS PRO VAL SEQRES 67 A 1015 LEU HIS ILE TYR ARG LEU VAL LEU GLU LYS VAL ASN ASN SEQRES 68 A 1015 CYS VAL ARG PRO SER LYS LEU HIS PRO ALA GLY TYR LEU SEQRES 69 A 1015 THR SER ALA ALA HIS LYS ALA SER GLN SER LEU LEU ASP SEQRES 70 A 1015 PRO LEU ASP LYS PHE ILE PHE ALA GLU ASN GLU TRP ILE SEQRES 71 A 1015 GLY ALA GLN GLY GLN PHE GLY GLY ASP HIS PRO SER ALA SEQRES 72 A 1015 ARG GLU ASP LEU ASP VAL SER VAL MET ARG ARG LEU THR SEQRES 73 A 1015 LYS SER SER ALA LYS THR GLN ARG VAL GLY TYR VAL LEU SEQRES 74 A 1015 HIS ARG THR ASN LEU MET GLN CYS GLY THR PRO GLU GLU SEQRES 75 A 1015 HIS THR GLN LYS LEU ASP VAL CYS HIS LEU LEU PRO ASN SEQRES 76 A 1015 VAL ALA ARG CYS GLU ARG THR THR LEU THR PHE LEU GLN SEQRES 77 A 1015 ASN LEU GLU HIS LEU ASP GLY MET VAL ALA PRO GLU VAL SEQRES 78 A 1015 CYS PRO MET GLU THR ALA ALA TYR VAL SER SER HIS SER SEQRES 79 A 1015 SER MODRES 1HWW ASN A 194 ASN GLYCOSYLATION SITE HET NAG A1101 14 HET ZN A1102 1 HET SWA A1103 12 HET MRD A1104 8 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETNAM SWA 1S-8AB-OCTAHYDRO-INDOLIZIDINE-1A,2A,8B-TRIOL HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN SWA SWAINSONINE FORMUL 2 NAG C8 H15 N O6 FORMUL 3 ZN ZN 2+ FORMUL 4 SWA C8 H15 N O3 FORMUL 5 MRD C6 H14 O2 FORMUL 6 HOH *985(H2 O) HELIX 1 1 MET A 45 MET A 52 1 8 HELIX 2 2 ASP A 71 TYR A 75 5 5 HELIX 3 3 THR A 98 ASP A 106 1 9 HELIX 4 4 ASP A 106 ASN A 121 1 16 HELIX 5 5 GLU A 130 HIS A 139 1 10 HELIX 6 6 GLY A 142 ASN A 155 1 14 HELIX 7 7 HIS A 174 ASN A 194 1 21 HELIX 8 8 PRO A 210 LYS A 218 1 9 HELIX 9 9 HIS A 230 GLN A 240 1 11 HELIX 10 10 ASP A 270 THR A 274 5 5 HELIX 11 11 ASP A 278 CYS A 283 1 6 HELIX 12 12 GLN A 284 ASP A 286 5 3 HELIX 13 13 ASN A 310 GLU A 327 1 18 HELIX 14 14 GLN A 346 GLN A 367 1 22 HELIX 15 15 ALA A 368 PHE A 370 5 3 HELIX 16 16 THR A 378 ALA A 392 1 15 HELIX 17 17 SER A 416 THR A 420 5 5 HELIX 18 18 ARG A 422 TRP A 445 1 24 HELIX 19 19 ASP A 449 ALA A 452 5 4 HELIX 20 20 ARG A 453 GLN A 469 1 17 HELIX 21 21 LYS A 479 LEU A 509 1 31 HELIX 22 22 PRO A 823 TYR A 828 5 6 HELIX 23 23 THR A 915 ASP A 927 1 13 HELIX 24 24 ASP A 998 LEU A 1002 5 5 HELIX 25 25 ASP A 1024 VAL A 1027 5 4 SHEET 1 A 6 VAL A 43 GLN A 44 0 SHEET 2 A 6 THR A 399 SER A 401 1 O THR A 399 N VAL A 43 SHEET 3 A 6 GLU A 244 TRP A 247 1 O LEU A 246 N LEU A 400 SHEET 4 A 6 LEU A 259 MET A 263 -1 O LEU A 259 N TRP A 247 SHEET 5 A 6 ASN A 223 ILE A 226 1 O MET A 224 N HIS A 262 SHEET 6 A 6 ALA A 199 ALA A 202 1 N SER A 200 O ASN A 223 SHEET 1 B 3 VAL A 333 ASP A 341 0 SHEET 2 B 3 LEU A 81 HIS A 90 1 O LYS A 82 N LEU A 334 SHEET 3 B 3 VAL A 372 PHE A 376 1 O GLN A 373 N VAL A 83 SHEET 1 C 2 PHE A 126 TRP A 128 0 SHEET 2 C 2 LEU A 158 PHE A 160 1 N GLU A 159 O PHE A 126 SHEET 1 D 2 ALA A 408 ARG A 410 0 SHEET 2 D 2 ASN A 413 TYR A 414 -1 N ASN A 413 O ARG A 410 SHEET 1 E 6 PHE A 524 LEU A 526 0 SHEET 2 E 6 ASP A 930 PHE A 934 -1 N ILE A 933 O THR A 525 SHEET 3 E 6 SER A 552 ASN A 559 -1 O HIS A 554 N PHE A 934 SHEET 4 E 6 GLY A 628 ILE A 636 -1 O GLY A 628 N ASN A 559 SHEET 5 E 6 VAL A 578 ASP A 582 -1 N SER A 579 O THR A 635 SHEET 6 E 6 PRO A 587 VAL A 588 -1 N VAL A 588 O VAL A 580 SHEET 1 F 5 PHE A 524 LEU A 526 0 SHEET 2 F 5 ASP A 930 PHE A 934 -1 N ILE A 933 O THR A 525 SHEET 3 F 5 SER A 552 ASN A 559 -1 O HIS A 554 N PHE A 934 SHEET 4 F 5 GLY A 628 ILE A 636 -1 O GLY A 628 N ASN A 559 SHEET 5 F 5 GLN A 945 PHE A 946 -1 O PHE A 946 N LEU A 629 SHEET 1 G 5 THR A 542 ILE A 543 0 SHEET 2 G 5 ARG A 565 VAL A 573 1 O TYR A 572 N ILE A 543 SHEET 3 G 5 THR A 606 VAL A 624 -1 O TYR A 616 N VAL A 573 SHEET 4 G 5 ALA A 590 ASP A 601 -1 O GLN A 591 N ILE A 619 SHEET 5 G 5 THR A 644 TYR A 646 1 O SER A 645 N VAL A 592 SHEET 1 H12 LYS A 669 GLY A 671 0 SHEET 2 H12 SER A 648 LEU A 652 1 O ASN A 649 N LYS A 669 SHEET 3 H12 VAL A 745 LYS A 749 -1 O VAL A 745 N LEU A 652 SHEET 4 H12 SER A 754 LEU A 760 -1 N SER A 755 O THR A 748 SHEET 5 H12 VAL A 763 MET A 769 -1 O VAL A 763 N LEU A 760 SHEET 6 H12 GLU A 775 VAL A 780 -1 O GLU A 775 N ILE A 768 SHEET 7 H12 VAL A 888 LYS A 898 -1 O VAL A 888 N VAL A 780 SHEET 8 H12 THR A 842 THR A 848 -1 N ARG A 843 O GLU A 897 SHEET 9 H12 GLY A 834 GLU A 838 -1 O MET A 835 N LEU A 846 SHEET 10 H12 ILE A 803 LEU A 808 -1 N TYR A 805 O PHE A 836 SHEET 11 H12 GLN A 812 ARG A 817 -1 O GLN A 812 N LEU A 808 SHEET 12 H12 ALA A 911 GLY A 912 -1 N GLY A 912 O PHE A 813 SHEET 1 I 8 TYR A 829 ILE A 831 0 SHEET 2 I 8 LEU A 852 SER A 855 -1 O LEU A 852 N ILE A 831 SHEET 3 I 8 GLU A 861 ARG A 869 -1 O GLU A 863 N SER A 855 SHEET 4 I 8 THR A 788 THR A 796 -1 O THR A 788 N ARG A 869 SHEET 5 I 8 VAL A 706 TYR A 715 -1 N HIS A 709 O GLU A 795 SHEET 6 I 8 LEU A 694 GLN A 698 -1 O LEU A 694 N PHE A 710 SHEET 7 I 8 THR A 685 PHE A 688 -1 N THR A 685 O GLN A 698 SHEET 8 I 8 ILE A 676 ARG A 679 -1 O ILE A 676 N PHE A 688 SHEET 1 J 6 TYR A 829 ILE A 831 0 SHEET 2 J 6 LEU A 852 SER A 855 -1 O LEU A 852 N ILE A 831 SHEET 3 J 6 GLU A 861 ARG A 869 -1 O GLU A 863 N SER A 855 SHEET 4 J 6 THR A 788 THR A 796 -1 O THR A 788 N ARG A 869 SHEET 5 J 6 VAL A 706 TYR A 715 -1 N HIS A 709 O GLU A 795 SHEET 6 J 6 SER A 736 PRO A 737 -1 N SER A 736 O LYS A 714 SHEET 1 K 5 LEU A 957 ARG A 964 0 SHEET 2 K 5 GLN A 973 ARG A 981 -1 N GLY A 976 O ARG A 963 SHEET 3 K 5 GLU A1035 HIS A1043 -1 O GLU A1035 N ARG A 981 SHEET 4 K 5 VAL A1006 THR A1012 -1 N ALA A1007 O SER A1042 SHEET 5 K 5 ASN A1019 HIS A1022 -1 N LEU A1020 O ARG A1011 SSBOND 1 CYS A 31 CYS A 1032 1555 1555 2.03 SSBOND 2 CYS A 275 CYS A 282 1555 1555 2.03 SSBOND 3 CYS A 283 CYS A 297 1555 1555 2.03 SSBOND 4 CYS A 902 CYS A 987 1555 1555 2.03 SSBOND 5 CYS A 1000 CYS A 1009 1555 1555 2.02 LINK ND2 ASN A 194 C1 NAG A1101 1555 1555 1.45 LINK NE2 HIS A 90 ZN ZN A1102 1555 1555 2.14 LINK OD1 ASP A 92 ZN ZN A1102 1555 1555 2.16 LINK OD1 ASP A 204 ZN ZN A1102 1555 1555 2.16 LINK NE2 HIS A 471 ZN ZN A1102 1555 1555 2.16 LINK ZN ZN A1102 O13 SWA A1103 1555 1555 2.30 LINK ZN ZN A1102 O11 SWA A1103 1555 1555 2.31 CISPEP 1 PHE A 405 THR A 406 0 0.30 CISPEP 2 TRP A 531 PRO A 532 0 -0.15 CRYST1 68.902 110.015 138.472 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014513 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009090 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007222 0.00000